GIVAX, Inc. is a biotech company that is backed by RA Ventures, the venture-focused arm of RA Capital Management, LP. GIVAX is developing novel oral vaccines to eliminate the burden of preventable GI disease in children & adults. Our lead program is a dual pediatric rotavirus / norovirus vaccine.

GIVAX, Inc.

Mario Barro

Fanny Cavalie

This department is focused on conducting research and analysis to support various projects and initiatives.

Research Division

This department focuses on developing and implementing operational strategies and programs to enhance organizational efficiency and effectiveness.

Strategic Operations

This department focuses on the research, development, and management of vaccine projects, including coordination of clinical and regulatory efforts.

Vaccine Development

This department oversees the management and coordination of laboratory activities to ensure efficient operations and effective scientific research.

GIVAX, Inc.

Org chart

Teams

Research Division

Strategic Operations

Vaccine Development

Laboratory Operations

Offices

GIVAX, Inc.

Org chart

Teams

Research Division

Strategic Operations

Vaccine Development

Laboratory Operations

Offices

Related companies